Principal Investigator/s:
Dr Graham Morrison

Name of the Study:
MAP

Why is this Study important?
To identify Crohn’s disease patients with systemic Mycobacterium avium subsp. paratuberculosis (MAP) infection using a new phage-based assay.

What the Study involves:
Recruitment of Crohn’s patients at Royal Victoria Hospital; written consent and 6 ml EDTA blood sample; testing for viable MAP using phage-based assay and culture methods.

Who can take part in the Study?
Adults with Crohn’s disease (new or established). Estimated 200–250 participants.

Contact Information:
Fiona Gregg / Nicola Milligan – Clinical Research Nurses

fiona.gregg@belfasttrust.hscni.net  | nicola.milligan@belfasttrust.hscni.net